National Center Reports Increase in Medical Device Adverse Event Reports for 2022
The National Center for Adverse Event Monitoring has released its national annual report regarding the...
NMPA
China’s NMPA, MPS, and NHC Announce Updates to Narcotics and Psychotropic Substances Catalog
The National Medical Products Administration (NMPA), Ministry of Public Security, and National Health Commission have...
NMPA Introduces Procedures to Adjust Chemical Generic Reference Preparations
The National Medical Products Administration (NMPA) has released a document outlining procedures for the adjustment...
NMPA Releases 65th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 65th batch of reference drugs for...
CDE Issues Guidelines for Real-World Drug Research and Evidence Framework
The Center for Drug Evaluation (CDE) has released two important documents: the “Guiding Principles of...
China’s NMPA Releases 64th Batch of Reference Drugs for Generic Quality Consistency Evaluation
China’s National Medical Products Administration (NMPA) has released the 64th batch of reference drugs for...
NMPA Proposes Emergency Use Management Measures for Medical Devices
The National Medical Products Administration (NMPA) has released the “Medical Device Emergency Use Management Measures”...
Ascletis Partners with Simcere for Ritonavir Supply in COVID-19 Drug Development
China-based Ascletis Pharma Inc. (HKG: 1672) has announced that its wholly-owned subsidiary Ascletis Pharmaceuticals Co.,...
NMPA Releases 63rd Batch of Reference Drugs for Generic Quality Evaluation
The National Medical Products Administration (NMPA) has released the 63rd batch of reference drugs for...
NMPA Approves Expanded Production for COVID-19 Symptom Treatments
The National Medical Products Administration (NMPA) has approved filings from multiple companies to expand manufacturing...
NMPA Strengthens Oversight of COVID-19 Drugs and Home Treatment Guidelines
The National Medical Products Administration (NMPA) has released a notification aimed at enhancing the quality...
NMPA Approves 172 Medical Devices for Marketing in November 2022
The National Medical Products Administration (NMPA) approved 172 medical devices for marketing in November 2022....
Simcere Receives NMPA Clearance for SIM0348 Clinical Study
China-based Simcere Pharmaceutical Group (HKG: 2096) has announced receiving clearance from the National Medical Products...
Immunotech Biopharm’s CAR-T-19-D2 IND Filing Accepted by NMPA
China-based chimeric antigen receptor T-cell (CAR-T) specialist Immunotech Biopharm Ltd (HKG: 6978) has announced that...
Acotec Scientific Holdings Receives NMPA Approvals for YAN and P-Conic Balloon
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced receiving market approvals from the National...
NMPA and GAC Release Notification on Import and Export Management of Narcotic Drugs
The National Medical Products Administration (NMPA) and the General Administration of Customs (GAC) have released...
Yipinhong’s AR882 Receives NMPA Approval for Gout Clinical Trial
China-based Yipinhong Pharmacy Co., Ltd (SHA: 300723) has announced that its pipeline candidate AR882, under...
Sirnaomics Announces Interim Results for STP705 in Phase IIb Study for isSCC
Sino-US siRNA therapy developer Sirnaomics Ltd (HKG: 2257) has announced the interim results of part...
NMPA Extends Validation Period for COVID-19 Antigen Detection Reagents
The National Medical Products Administration released a notification extending the validation period of approvals for...
CSPC and Ascletis Get NMPA Approval for COVID-19 Drug Clinical Trials
China-based firms CSPC Pharmaceutical Group Ltd (HKG: 1093) and Ascletis Pharma Inc. (HKG: 1672) both...